LYMPHOMA, MANTLE-CELL
Clinical trials for LYMPHOMA, MANTLE-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, MANTLE-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, MANTLE-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug cocktail takes on tough lymphoma
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—glofitamab, venetoclax, and zanubrutinib—in people with high-risk mantle cell lymphoma, either newly diagnosed or after relapse. The study will enroll 100 participants across three groups based on their treatment history.…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called LY4152199 in about 215 adults with certain types of blood cancer (like follicular lymphoma or diffuse large B-cell lymphoma) that have already been treated. The drug is designed to help the body's immune cells attack the cancer. The …
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC